NTRP vs. JCSE, HEPA, GHSI, AZRX, ACST, SNSS, AMCR, BRC, HI, and ARRY
Should you be buying Neurotrope stock or one of its competitors? The main competitors of Neurotrope include JE Cleantech (JCSE), Hepion Pharmaceuticals (HEPA), Guardion Health Sciences (GHSI), AzurRx BioPharma (AZRX), Acasti Pharma (ACST), Sunesis Pharmaceuticals (SNSS), Amcor (AMCR), Brady (BRC), Hillenbrand (HI), and Array Technologies (ARRY).
Neurotrope (NASDAQ:NTRP) and JE Cleantech (NASDAQ:JCSE) are both consumer discretionary companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.
In the previous week, Neurotrope's average media sentiment score of 0.00 equaled JE Cleantech'saverage media sentiment score.
Neurotrope received 180 more outperform votes than JE Cleantech when rated by MarketBeat users.
3.8% of Neurotrope shares are held by institutional investors. Comparatively, 0.0% of JE Cleantech shares are held by institutional investors. 9.7% of Neurotrope shares are held by insiders. Comparatively, 64.0% of JE Cleantech shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Neurotrope has a beta of 1.65, suggesting that its share price is 65% more volatile than the S&P 500. Comparatively, JE Cleantech has a beta of -0.24, suggesting that its share price is 124% less volatile than the S&P 500.
JE Cleantech has higher revenue and earnings than Neurotrope.
JE Cleantech has a net margin of 0.00% compared to Neurotrope's net margin of -1,123.90%. JE Cleantech's return on equity of 0.00% beat Neurotrope's return on equity.
Summary
JE Cleantech beats Neurotrope on 6 of the 9 factors compared between the two stocks.
Get Neurotrope News Delivered to You Automatically
Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NTRP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Neurotrope Competitors List
Related Companies and Tools
